PROZAC Caps. 20 mg

국가: 요르단

언어: 영어

출처: JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

유효 성분:

Fluoxetine 20 mg

제공처:

شركة مستودع الادوية العربي - THE ARAB DRUG STORE P.S.C

ATC 코드:

N06AB03

INN (국제 이름):

Fluoxetine 20 mg

복용량:

20 mg

패키지 단위:

14

Manufactured by:

PATHEON/FRANCE (فرنسا)

제품 요약:

3.89 :سعر الجمهور + الضريبة

환자 정보 전단

sens lecture
code laetus
PLI
RECTO
VERSO
__
__
dÉFIleMent
recto 1
COULEUR(S) PANTONE
DANS L’ORDRE PRÉVU
D’IMPRESSION:
code artIcle
MU3071_NOT
descrIPtIF tecHnIQue de l’artIcle
(Issu 7065741)
NOTICE TRIPLE PLIÉE
(l05)
PROZAC 20 MG / GÉLULES / EXPORT
V2_14 Jun 2016
laIZe
170 MM
NOIR
du noIr
TRAMES:
LINÉATURE: 150 LPI
INCLINAISON :
taille mini du texte : 7,5 PT tableau : 6,5
Plan de dÉrouleMent n° 14
code laetus : 276
dIMensIons : 250 X 170 MM
dÉPlIÉe : 250 X 510 MM
responsable: M
r
Franc Pascal
PATHEON France
40, boulevard de Champaret
CS 11006 – 38307 Bourgoin-Jallieu Cedex
tél.: [phone] fax.: [phone]
RECTO / VERSO
EN ROULEAU / P. 1
1
eusPc03Mar2016
PROZAC
FLUOXETINE HYDROCHLORIDE
1.
NAME OF THE MEDICINAL PRODUCT
Prozac* 20 mg hard capsules
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
each capsule contains 20 mg of fluoxetine (as fluoxetine
hydrochloride).
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Hard capsules.
the capsules are green and yellow, printed ‘lilly 3105’
.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
ADULTS:
Major depressive episodes.
obsessive-compulsive disorder.
Bulimia nervosa: Prozac is indicated as a complement of psychotherapy
for the reduction of binge-eating and purging activity.
CHILDREN AND ADOLESCENTS AGED 8 YEARS AND ABOVE:
Moderate to severe major depressive episode, if depression is
unresponsive to psychological therapy after 4–6 sessions.
antidepressant
medication should be offered to a child or young person with moderate
to
severe depression only in combination with a concurrent psychological
therapy.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_Adults_
_Major depressive episodes_
adults and the elderly: the recommended dose is 20 mg daily. dosage
should be reviewed and adjusted if necessary within 3 to 4 weeks of
initiation of therapy and thereafter as judged clinically appropriate.
although there may be an increased potential for undesirable effects
at higher doses, in some patients, with insufficien